Request Free Sample ×

Kindly complete the form below to receive a free sample of this Report

* Please use a valid business email

Leading companies partner with us for data-driven Insights

clients tt-cursor

Oral Doxycycline Hyclate Companies

ID: MRFR/HC/10634-HCR
128 Pages
Rahul Gotadki
Last Updated: February 16, 2025
Doxycycline hyclate is an antibiotic medication that belongs to the tetracycline class. Doxycycline hyclate is an antibiotic used to treat various bacterial infections. It is commonly prescribed to treat a variety of bacterial infections. Doxycycline hyclate works by inhibiting the growth of bacteria. It does so by preventing the bacteria from producing proteins necessary for their survival. This antibiotic is effective against a broad spectrum of bacteria.
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Oral Doxycycline Hyclate Market
Market Size
Forecast Period2025 - 2035
CAGR (2025 - 2035)9.6%
2024 Market Size$ 5.04 Billion
2025 Market Size$ 5.53 Billion
2035 Market Size$ 13.82 Billion
Key Players
Teva Pharmaceuticals
Mylan
Sandoz
Aurobindo Pharma
Lupin Pharmaceuticals
Sun Pharmaceutical Industries
Opportunities
  • Growth in Veterinary Applications
  • Expansion of Healthcare Infrastructure
  • Rising Awareness of Antibiotic Treatments

Top Industry Leaders in the Oral Doxycycline Hyclate Market

Oral Doxycycline Hyclate Key Companies
 
Latest Oral Doxycycline Hyclate Companies Update

Teva Pharmaceuticals (Israel) Acquired Actavis, gaining access to doxycycline hyclate products and strengthening its position in the generics market.

Sun Pharma (India) Launched Doxicaps Plus, a doxycycline-clavulanate potassium combination product for treating antibiotic-resistant bacterial infections.

Lupin (India) Received FDA approval for its doxycycline hyclate delayed-release capsules, offering a potential solution to gastrointestinal side effects.

Alkem Laboratories (India) Partnered with Cipla to expand marketing and distribution of doxycycline hyclate products in Africa.

Pfizer (US) Continues to hold a significant market share with its branded formulation of doxycycline, Vibramycin.

List of Oral Doxycycline Hyclate Key Companies in the Market

  • Zydus Pharmaceuticals
  • G&W Laboratories
  • Ajanta Pharma
  • Amneal Pharmaceuticals
  • Prinston Pharmaceutical
  • Alembic Pharmaceuticals
  • Novel Laboratories
  • Emcure
  • Teva
  • Heritage Pharmaceuticals
  • Almirall
  • Mayne Pharma
  • Par Pharmaceutical
  • Sun Pharmaceutical
  • Mylan